CaseVu
Precipio And Nucleai Partner To Develop Artificial Intelligence-Powered Hemepath Solution
System will support Hematopathologists in accurately identifying abnormalities to ensure diagnostic accuracy NEW HAVEN, CT, [...]
Jun
Precipio Updates Commercial Pipeline For Its ICE-COLD PCR™ Liquid Biopsy Technology
Trials underway at five laboratories and two diagnostic equipment companies NEW HAVEN, CT, (June 19th, [...]
Jun
Precipio Inc. Announces Adjournment Of Annual Meeting Of Shareholders
NEW HAVEN, CT, (June 15th, 2018) – Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), announced today that [...]
Jun
Precipio Reminds Shareholders To Vote Before The Annual General Meeting On June 15, 2018
NEW HAVEN, CT, (June 14th, 2018) – Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), today reminded its [...]
Jun
Precipio Reminds Shareholders To Vote Before The Annual General Meeting On June 15, 2018
NEW HAVEN, CT, (June 12th, 2018) – Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), today reminded its [...]
Jun
Precipio Strengthens Patent Portfolio With Expanded Reagent Claims For Its Liquid Biopsy Enabling DNA Mutation Enrichment Technology
NEW HAVEN, CT, (June 06th, 2018) – Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), today announced the [...]
Jun
Precipio Launches Liquid Biopsy DNA Enrichment Sales In Europe With First Order
$10 million annual Europe market anticipated with $1 million annual addressable sales potential from local [...]
May
Potential Sequential Revenue Run-Rate Growth Of 30% Over Q1, Based On Preliminary April Results
Revenue growth accelerating as new sales initiatives and expanded team gain traction NEW HAVEN, CT, [...]
Precipio Launches ICE COLD-PCR™ Liquid Biopsy Reagent For Pancreatic Cancer
Ultra-sensitive enrichment reagent enables development of low cost detection tests, allowing optimized patient treatment NEW [...]
May
Precipio Announces Preliminary Q1 2018 Year-Over-Year Revenue Increase Of 286%
Growth resulting from commercial team reorganization, product and service cross-selling, and increased business stabilization NEW [...]
May